Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SunP Biotech
AddedFeb 16, 2024
UpdatedJun 18, 2026
SunP Biotech

SunP Biotech

SunP Biotech: Pioneering in 3D bio-printing and tissue engineering for advanced drug discovery and testing.

HQ
Cherry Hill, NJ, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

SunP Biotech, founded with a mission to revolutionize tissue engineering and 3D bio-printing, focuses on developing cutting-edge 3D bio-printing systems. The company aims to advance drug discovery, testing, and personalized tissue engineering through its proprietary technologies. SunP Biotech's product lineup includes 3D bio-materials printing systems, 3D cell printing systems, and cell/tissue/organ-on-a-chip solutions, targeting the biomedical research and pharmaceutical markets.

Notable affiliations include partnerships with prestigious institutions like Columbia University and Wuhan Textile University, which have endorsed SunP Biotech's reliable and effective bio-printers. The company has achieved significant milestones in the field of tissue engineering, contributing to advancements in drug testing and personalized medicine. SunP Biotech's innovative solutions have made a substantial impact on the research community, fostering new possibilities in medical science and biotechnology.

SunP Biotech - Similar Companies

Systemic Bio logo

Systemic Bio

systemic.bio

3DBio logo

3DBio

3dbiocorp.com

3D Biotek logo

3D Biotek

3dbiotek.com

VivoSim Labs logo

VivoSim Labs

organovo.com

Precise Bio logo

Precise Bio

precise-bio.com

SE3D logo

SE3D

BioSapien logo

BioSapien

biosapien.com

RealBio Technology logo

RealBio Technology

ChemoSen3D logo

ChemoSen3D

chemosen3d.com

Spheringenics logo

Spheringenics

Stämm logo

Stämm

stamm.bio

Ortuvo logo

Ortuvo

ortuvo.com

Satellite Bio logo

Satellite Bio

satellite.bio

Solar Biotech logo

Solar Biotech

solarbiotech.com

Curi Bio logo

Curi Bio

curibio.com

SunP Biotech - Quick Facts

Who are SunP Biotech's competitors?

Companies similar to SunP Biotech include Systemic Bio, 3DBio, 3D Biotek and VivoSim Labs.

When was SunP Biotech founded?

SunP Biotech was founded in 2014.

Where is SunP Biotech's headquarters located?

SunP Biotech's headquarters is located in Cherry Hill, NJ, US.

When was SunP Biotech's last funding round?

SunP Biotech's most recent funding round was for $4.3M (USD) in January 2019.

How much has SunP Biotech raised to-date?

As of Jan 31, 2019, SunP Biotech has raised a total of $4.3M (USD).

How many employees does SunP Biotech have?

SunP Biotech has 30 employees as of Feb 4, 2024.

SunP Biotech - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Bioprinting
  • Tissueengineering
Tags
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software